How is L-carnitine injection dosed, and how many mL is a dose?
| Product | Strength | Vial and carton |
|---|---|---|
| Carnitor injection1 | 1 g per 5 mL (200 mg/mL) | single dose vials, 5 vials per carton |
| Gland Pharma generic3 | 200 mg/mL | 1 g per 5 mL single dose vials, 5 vials per carton |
| Hikma generic2 | 200 mg per 1 mL | 5 mL single dose vials, 10 vials per carton |
The Carnitor label gives 50 mg/kg as a slow 2-3 minute intravenous bolus or infusion for metabolic disorders, and a starting dose of 10-20 mg/kg dry body weight after each dialysis session for patients with end stage renal disease on hemodialysis, from a 200 mg/mL solution in 5 mL vials for intravenous use only, so each 1 mL holds 200 mg.123
What the vial holds and how many mL a dose is
The table is set at the top of the page
At 200 mg/mL, the 1000 mg dose given in the Kurume University trial by Sugiyama and colleagues, of 57 hemodialysis patients, is 5 mL.41 The Carnitor label gives a sterile aqueous solution of 1 g of levocarnitine per 5 mL vial, searches found no label for a powder or for mixing with bacteriostatic or sterile water.1
The Carnitor label gives the injection as intravenous only; the app's own entry, not a sourced figure, lists oral and intramuscular.1 Searches of PubMed and ClinicalTrials.gov returned no human trial of subcutaneous or intramuscular L-carnitine, and the saved labels list no subcutaneous or intramuscular route.
What the label and the trials used
The Carnitor label gives 50 mg/kg for metabolic disorders, as a slow 2-3 minute bolus or an infusion.1 The label gives it q3h or q4h, and never less than q6h, by infusion or by intravenous injection.1 All subsequent daily doses are given as in the range of 50 mg/kg or as therapy may require.1 The highest dose the label reports as administered is 300 mg/kg.1 For patients on hemodialysis it gives a starting dose of 10-20 mg/kg dry body weight as a slow 2-3 minute bolus into the venous return line after each dialysis session, with downward adjustments guided by trough levels, such as to 5 mg/kg, possible as early as the third or fourth week.1
The dialysis trials below gave L-carnitine intravenously; a pharmacokinetic study by Harper and colleagues gave single intravenous and oral doses of 2 g and 6 g to 6 healthy subjects on a low carnitine diet.5
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| CHIEF study A (Brass)6 | 20 mg/kg IV at the end of each thrice-weekly dialysis, against placebo | 28 on L-carnitine, 28 on placebo | 24 weeks |
| CHIEF study B (Brass)6 | 10, 20 or 40 mg/kg IV, or placebo, as in study A | 32, 30 and 32 on L-carnitine, 33 on placebo | not stated separately |
| Kurume University (Sugiyama)4 | 1000 mg (5 mL) IV three times weekly, or once weekly plus saline placebo, against placebo, in patients already on 1000 mg per session | 57 patients: 19 and 18 on L-carnitine, 20 on placebo | six months |
| Karachi (Rehman)7 | 20 mg/kg IV bolus over 2-3 min after each hemodialysis session thrice a week for 20 weeks, then an oral maintenance dose of 500 mg, against oral 500 mg three times daily | 51 per group; 34 IV and 49 oral analysed | 24 weeks in total |
| Duranay8 | IV three times a week after each haemodialysis session at 20 mg/kg, in patients maintaining carnitine supplementation | 21 on L-carnitine, 21 controls not receiving carnitine | measured at 3 and 6 months |
None of the saved labels or trials gives a cycle length for injected L-carnitine; they give only the dialysis and metabolic schedules above. Milligram's logs give no L-carnitine figure to report.
How L-carnitine injection is stored
The Carnitor label says to store vials at controlled room temperature (25°C) and protect them from freezing, and the Gland Pharma label gives 20° to 25°C and also says to protect from freezing.13 The Hikma label gives 20° to 25°C and says to protect from light.2 All three say to discard the unused portion of a vial once it has been entered, as it has no preservative.132 The Carnitor label gives up to 24 hours at room temperature (25°C) once mixed into 0.9% sodium chloride or Lactated Ringer's at 0.5 to 8.0 mg/mL in PVC plastic bags; searches returned no stability data for a drawn-up syringe.1
Frequently asked questions
What did oral L-carnitine trials for weight loss use?
An 8-week trial by Villani and colleagues of 36 moderately overweight premenopausal women, all walking 30 min 4 days/week, gave 2 g twice daily against lactose and found no significant change in body mass or fat mass among those who completed.9 A meta-analysis by Pooyandjoo and colleagues of nine trials in adults, with 911 people in total, found that those given carnitine lost 1.33 kg more than controls (95% CI -2.09 to -0.57), and that the loss fell significantly over time on meta-regression; the saved text gives no dose.10
What side effects does the injection label list?
The Carnitor label lists transient nausea and vomiting, with body odor, nausea and gastritis less frequent, and warns of serious hypersensitivity reactions, mostly in patients with end stage renal disease who are undergoing dialysis.1
References
- Leadiant Biosciences (DailyMed). CARNITOR ® (levocarnitine) Injection 1 g per 5 mL vial For Intravenous Use Only. 2023. dailymed.nlm.nih.gov
- DailyMed generic levocarnitine injection. Levocarnitine Injection, USP. 2023. dailymed.nlm.nih.gov
- DailyMed generic levocarnitine injection. Levocarnitine Injection, USP 1 g per 5 mL vial For Intravenous Use Only. Rx Only. 2026. dailymed.nlm.nih.gov
- PMC. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial. 2021. pmc.ncbi.nlm.nih.gov
- PubMed. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. 1988. pubmed.ncbi.nlm.nih.gov
- PubMed. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. 2001. pubmed.ncbi.nlm.nih.gov
- PMC. Efficacy of Intravenous Versus Oral Administration of Levocarnitine in Maintenance Hemodialysis Patients: A Randomized Controlled Trial Investigating Therapeutic Approaches to Renal Anemia. 2025. pmc.ncbi.nlm.nih.gov
- PubMed. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients. 2006. pubmed.ncbi.nlm.nih.gov
- PubMed. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. 2000. pubmed.ncbi.nlm.nih.gov
- PubMed. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. 2016. pubmed.ncbi.nlm.nih.gov